Creo Medical Limited
LSE: CREO.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Craig Jonathan Gulliford
- Employees
- 278
- Headquarters
- Chepstow, United Kingdom
- IPO year
- 2016
- Market cap
- £52.1M
- Website
- https://creomedical.com
Loading CREO…
Loading profile data…Frequently asked questions about CREO
What does Creo Medical Limited (CREO.L) do?
Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an e...
Where does CREO.L trade?
Creo Medical Limited (CREO.L) trades on the London Stock Exchange.
What sector is CREO.L in?
Creo Medical Limited (CREO.L) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Creo Medical Limited?
Craig Jonathan Gulliford is the chief executive officer of Creo Medical Limited (CREO.L).
Where is Creo Medical Limited headquartered?
Creo Medical Limited is headquartered in United Kingdom.
Does CREO.L pay a dividend?
Creo Medical Limited (CREO.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CREO.L go public?
Creo Medical Limited (CREO.L) completed its initial public offering in 2016.